Impaired glucose tolerance, Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 35-65 years; 2. Diagnose IGT after OGTT, no serious heart, liver, kidney, lung dysfunction; 3. Informed consent; 4. Agreement on no other drug therapy on IGT during trial.
Exclusion criteria
Exclusion criteria: 1. No serious heart, liver, kidney, lung dysfunction, no diabetes; 2. Probiotic allergy; 3. Suspected or confirmed history of alcohol, drug abuse, or may change the work environment frequently according to the investigator's judgment; 4. Have participated in other clinical trials in the past three months; 5. Some other possible situations not suitable to this trial judged by observers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood glucose; | — |
Secondary
| Measure | Time frame |
|---|---|
| lipids; | — |
Countries
China
Contacts
Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, China.